Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 38, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Editor's Note: The "Qiming Weekly" column publishes regularly every week, rounding up funding news and development updates from Qiming Venture Partners' portfolio companies.
In the wave of technology and innovation, every step entrepreneurs take is worth recording. Qiming Venture Partners will continue to accelerate and empower entrepreneurs, and join you in celebrating the milestone moments of our portfolio companies.
Major Partnerships
01/
Yunji and Meituan Upgrade Hotel Food Delivery Experience for Nearly 20,000 Hotels
Recently, Qiming Venture Partners portfolio company Yunji Technology (02670.HK) completed upgrades to 18,000 Meituan hotel "Xiaodai" units. The "Xiaodai Fast Delivery Relay" model, jointly developed with Meituan Food Delivery, has been deployed at scale across nearly 20,000 hotels nationwide, now processing over 10,000 food delivery orders daily. This marks the official end of "human transfer" for hotel food delivery last-mile logistics, ushering in an intelligent era of seamless "rider-to-robot" handoffs.
By integrating Meituan Food Delivery's system with Yunji's robot service system, riders simply scan the robot's QR code through the Meituan app or WeChat, automatically linking the order information to enable a complete closed loop of "scan to deposit, robot delivery, full-chain visibility."
The deep collaboration between Yunji Technology and Meituan (03690.HK) represents an elevation of capabilities and validates the powerful vitality of the "technology + scenario + ecosystem" model. In the near term, it dramatically improves operational efficiency in hotel scenarios and alleviates industry pain points; in the long term, the partners are building a warm, high-engagement service ecosystem by expanding scenario entry points.
02/
Hesai Technology LiDAR Powers Great Wall Motor's All-New Tank 400 Pre-Sale
Recently, the pre-sale launch event for the all-new Tank 400 — standard-equipped with Qiming Venture Partners portfolio company Hesai Technology (NASDAQ: HSAI, 02525.HK) LiDAR — was successfully held. Great Wall Motor introduced the all-new Tank 400 Hi4-Z Premium Edition and Tank 400 Hi4-T Premium Edition. Building on three core strengths — mecha aesthetics, hardcore performance, and luxury intelligence — the all-new Tank 400 is positioned to set the value benchmark for trendy, cool off-road SUVs, leading the charge into a new era of stylish off-roading.
As intelligent mobility equipment for young people, the all-new Tank 400 carries 27 driver-assist sensors including LiDAR, employing the industry-first-tier Coffee Pilot Ultra advanced driver-assistance system to achieve full-scenario coverage of urban NOA and highway NOA. Its fully integrated parking system supports over 200 parking space types, truly delivering "park wherever visible" convenience. Going forward, Hesai Technology will continue to deepen its cooperation with Great Wall Motor, bringing consumers smarter, safer, and more efficient mobility choices.
03/
HyperStrong Signs Large-Scale Energy Storage Project in the Philippines, Advancing Southeast Asia Market Layout
Recently, Qiming Venture Partners portfolio company and global leading energy storage system solutions and technical services provider HyperStrong (688411.SH) celebrated two milestones in the Philippines market. On October 10, HyperStrong officially opened its office in Manila's BGC financial district, and one week later successfully signed a 185MWh large-scale energy storage system project serving the local market. This series of tightly coordinated strategic moves marks a solid step forward for HyperStrong in Southeast Asia, demonstrating its resolve to deeply cultivate the Philippine and broader Southeast Asian markets.
At the project signing ceremony, the client spoke highly of the project's significance for the Philippines' energy transition and grid stability enhancement. HyperStrong Senior Vice President of International Business Qiu Changbin stated: "We are honored to provide customers with reliable energy storage solutions through our leading technical capabilities and extensive global project experience. This successful signing reflects HyperStrong's comprehensive strengths and also marks the starting point for long-term strategic cooperation with local partners."
04/
WeRide and Uber Launch Public Robotaxi Operations in Riyadh
Recently, Qiming Venture Partners portfolio company WeRide (NASDAQ: WRD) and Uber (NYSE: UBER) announced the launch of public Robotaxi operations in Riyadh, the capital of Saudi Arabia. This marks the first time autonomous vehicles have gone live on the Uber App in Saudi Arabia, and represents a major milestone in the cooperation among WeRide, Uber, and the Saudi General Transport Authority (TGA) to advance autonomous driving deployment — highly aligned with Saudi Vision 2030's ambitious goals of leading intelligent, sustainable mobility innovation.
Effective immediately, Uber passengers traveling between the prominent Roshn Front commercial district and Princess Nourah University in Riyadh will have the opportunity to be matched with WeRide's next-generation mass-production Robotaxi GXR, experiencing the future of Saudi mobility.
WeRide CFO and Head of International Li Xuan stated: "We are proud to partner with Uber to bring WeRide's latest Robotaxi GXR service to the public in Riyadh. This is not only another important milestone in WeRide's global expansion, but also a key step in Saudi Arabia's journey toward intelligent and sustainable transportation. With world-leading autonomous driving technology, our goal is to enhance people's daily travel experience and help build safer, greener, and more efficient future cities across Saudi Arabia and beyond."
05/
Visual China Group and Shengshu Technology Formally Establish Strategic Partnership to Build "Traceable, Commercial-Ready" AIGC Content Ecosystem
Recently, Visual China Group and Qiming Venture Partners portfolio company Shengshu Technology formally established a strategic partnership. The two parties will conduct in-depth cooperation around "compliant data + multimodal large models + scenario applications," jointly building a traceable, commercial-ready generative AI visual content ecosystem to provide global creators and enterprise clients with more intelligent, efficient, and compliant visual content solutions. Previously, Visual China and its controlling subsidiary Guangchang Creative jointly participated in Shengshu Technology's Series A funding round. This collaboration represents an important step in further strengthening ecological synergy between the two parties.
This cooperation will achieve deep integration of Visual China Group's massive compliant content resources with Shengshu Technology's advanced multimodal generation technology, forming a complete closed loop from data supply, model training to scenario application.
As a global-leading multimodal large model, through its cooperation with Visual China Group, Shengshu Technology will further strengthen synergies in technology and resources. The Vidu model's technical advantages in multi-shot generation, spatiotemporal consistency, and physical world simulation, combined with Visual China's massive content resources and application scenarios, will not only significantly improve the efficiency and quality of visual content creation, but also accelerate the scaled deployment of AIGC technology in the creative industries.
Going forward, both parties will adhere to a dual-wheel-drive philosophy of "resources + technology," continuously expanding application scenarios for multimodal generation technology and jointly advancing innovation and upgrading of the visual industry in the AIGC era.
06/
Shengshu Technology's Vidu Partners with Grandpa Hua Studio to Launch First AI Chinese-Style Animation Across Multiple Platforms
Recently, the 42-minute animated feature One-Palm Panda, jointly created by Shengshu Technology's Vidu and Grandpa Hua Studio, officially launched across Douyin, Bilibili, Weibo, WeChat Channels, and other major platforms, bringing a new story featuring China's beloved giant panda. Dubbed "China's WALL-E," this AI-animated film is a co-production of Grandpa Hua AI Studio, Broadmedia, and Vidu AI. Using Vidu's reference-to-video generation and other capabilities, the project demonstrated through a technical experiment that AI video is no longer simply about "generating video" — it can now "generate masterful acting."
Qin Wenshan, head of Grandpa Hua AI Studio, said: "AI has lowered the barrier for short-form production. But until now, China hadn't produced a feature-length AI animated series with photorealistic CG cinematography. Through One-Palm Panda, we hope to more deeply explore the expressive boundaries of current AI video models for long-form storytelling, and to validate AI's enormous potential in handling complex narratives and even AI filmmaking. One-Palm Panda was entirely generated by Vidu AI. Its release is not just a technical breakthrough, but a fusion and contest between complex narrative and artistic expression."
07/
Unisound Partners with Fangchenggang, Guangxi to Build "AI + Healthcare" Guangxi Model, Creating a Smart Healthcare Regional Benchmark
Recently, Unisound (09678.HK), a Qiming Venture Partners portfolio company, formally reached a strategic partnership with Fangchenggang City to jointly advance the systematic construction of "AI + healthcare." Under this cooperation framework, Unisound signed a specific implementation agreement with the Fangchenggang Municipal Health Commission, which will serve as the executing body to comprehensively promote the deep integration and scenario-based application of AI technology in medical care and wellness.
According to the agreement, both parties will fully leverage their respective core strengths in public health services and artificial intelligence technology, adhering to the principles of "co-construction and sharing, mutual benefit and win-win, and collaborative development." Together they will advance the construction of Fangchenggang's "AI + healthcare" and "AI + wellness" systems, injecting new momentum into the transformation and upgrading of regional medical and health services. Going forward, the partnership will focus on six key areas of deep cooperation: digital and intelligent transformation of healthcare services, quality upgrading of grassroots informatization, regional "AI + healthcare" infrastructure construction, innovation in coordinated "three healthcare" management models, construction of multilingual healthcare service platforms, and industrial collaboration with the International Medical Open Experimental Zone.
08/
Qingdao Film Academy Partners with Shengshu Technology to Co-Build Vidu Future Technology Academy
The 15th Anniversary High-Quality Development Conference of Qingdao Film Academy was grandly held. As a key agenda item, Qingdao Film Academy and Shengshu Technology, a Qiming Venture Partners portfolio company, formally held a strategic cooperation signing ceremony, jointly unveiling the "Qingdao Film Academy Vidu Future Technology Academy" and co-founding Qingying Shengshu Film & Television Technology Co., Ltd.
The two parties will focus on three directions — technology R&D, content generation, and talent cultivation — to further strengthen the academy's capabilities in intelligent film education and creative practice, build a new paradigm of industry-education integration, promote large model technology-driven transformation in film creation and educational innovation, and cultivate versatile professionals equipped for the future development of the film industry.
09/
DeepWise and Dipeptide Deep Collaboration Jointly Release AI+Click Platform, Completing Novel Scaffold Hit Discovery in Two Weeks
Recently, at the 2025 World Laureates Conference, DeepWise and Dipeptide Deep Collaboration jointly released the AI+Click Function Molecule Discovery Platform (AI-Clicked Discovery Platform for Functional Molecules). The platform innovatively integrates Click Chemistry with the AI for Science modeling system, constructing an intelligent molecule discovery framework based on synthesizable chemical space. Across four different protein targets, the platform achieved a complete closed loop from de novo molecular design, synthesis to experimental validation in just two weeks, obtaining novel scaffold micromolar-level active compounds. This accomplishment shortens the traditional drug hit discovery cycle from months to weeks, significantly improving the efficiency and reliability of functional molecule R&D, and demonstrating a new "synthesizable-discoverable" intelligent R&D model for functional molecules.
Dr. Zheng Xing, Chief Engineer of Biomedical R&D at DeepWise, stated: "Leveraging the reliable synthesis capabilities of click chemistry, we completed a full iteration from computation to experiment within two weeks. This provides an unprecedented demonstration space for AI for Science to close the loop from computational discovery to real-world validation."
Going forward, both teams will continue to expand high-reliability reaction systems, broaden coverage of synthesizable chemical space, and combine more powerful and diverse AI for Science modeling capabilities to push functional molecule discovery into a new stage that is more intelligent and more reliable.
R&D Progress
01/
Zai Lab Announces Latest Phase 1 Clinical Data for ZL-1310 and Initiates Global Phase 3 Registration Study
Recently, Zai Lab (NASDAQ: ZLAB, 09688.HK), a Qiming Venture Partners portfolio company, announced the latest data from the global Phase 1 clinical study (NCT06179069) of zocilurtatug pelitecan (hereinafter referred to as zoci, formerly ZL-1310), showing strong and durable treatment responses in heavily pre-treated extensive-stage small cell lung cancer (ES-SCLC) patients.
Dr. Rafael G. Amado, President and Global Head of R&D at Zai Lab, said: "The strong and durable anti-tumor activity demonstrated by zoci, along with its favorable safety profile, highlight its potential to become a best-in-class DLL3-targeting ADC for the treatment of SCLC. Advancing this program from Phase 1 to a global registration study in less than two years reflects our team's speed, scientific rigor, and excellent execution, marking an important milestone in Zai Lab's advancement of global programs. We are rapidly expanding zoci into other areas of high unmet need, including first-line SCLC treatment and neuroendocrine carcinoma, with both programs expected to enter registration studies next year."
02/
Dingtail Pharmaceutical Research Group Supports Jianda Jiuzhou AAV Ophthalmic Gene Therapy Drug GA001 Injection in Receiving FDA Approval to Enter Phase II Clinical Trials
Recently, GA001 injection, a Class I therapeutic biological product independently developed by Jianda Jiuzhou, was evaluated by the FDA and has formally received clinical trial approval, permitting the initiation of Phase II efficacy and safety studies. The product is being developed for the treatment of retinitis pigmentosa. Dingtail Pharmaceutical Research Group, a Qiming Venture Partners portfolio company, served as the main collaborator for the non-clinical research work on the GA001 project. Leveraging its professional technical capabilities and extensive experience in ophthalmic project evaluation, the group completed the non-clinical research for the GA001 project in a compliant, high-quality, and efficient manner, and provided SEND data conversion and FDA registration filing document preparation services, accelerating the drug's development process.
As a new-type CRO specializing in disease-specific R&D enablement, Dingtail Pharmaceutical Research Group has been committed to the non-clinical and clinical research of frontier technology drugs including AAV gene therapy drugs, and has supported the rapid translation of multiple ophthalmic new drugs both domestically and internationally, covering various ocular indications including age-related macular degeneration, choroidal neovascularization, diabetic retinopathy, glaucoma, cataract, pterygium, and dry eye disease.
03/
Abbisko Pharma Announces Latest Research Results for Two Preclinical Pipeline Programs
Recently, Qiming Venture Partners portfolio company Abbisko Pharma (02256.HK) presented the latest research findings for two preclinical pipeline programs — CDK4/2 inhibitor ABK-CDK-1 and SMARCA2 PROTAC degrader ABK-SM2-1 — at the 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Both demonstrated excellent preclinical characteristics.
Abbisko Pharma's ABK-CDK-1 is a novel, selective, blood-brain-barrier-penetrant CDK4/2 inhibitor with the potential to overcome the limitations of existing CDK4/6 inhibitors. Its excellent efficacy, selectivity, and other properties support further preclinical advancement and progression to clinical development. ABK-SM2-1 also demonstrated strong preclinical characteristics, supporting its continued preclinical development.
04/
Dingtail Pharma Group Supports Alphamab Oncology's ADC Drug JSKN022 in Receiving NMPA IND Clinical Trial Approval
Recently, Alphamab Oncology's independently developed PD-L1/αvβ6 bispecific antibody-drug conjugate (ADC) JSKN022 received clinical trial implied approval from the Center for Drug Evaluation, NMPA (CDE) (application number CXSL2500648), for the treatment of advanced solid tumors. Qiming Venture Partners portfolio company Dingtail Pharma Group served as the primary collaborator for the GA001 project's non-clinical research work, completing the non-clinical safety evaluation and pharmacokinetic studies for JSKN022 in a compliant, high-quality, and efficient manner, thereby accelerating the product's clinical approval.
Dingtail Pharma Group has for years focused on non-clinical evaluation and clinical research of ADC drugs, accumulating experience with nearly 50 ADC drug programs and laying a solid foundation for partners to rapidly advance PCC determination and clinical trial entry.
Product Launches
01/
Zhipu AI Launches GLM Coding Plan Enterprise Edition
Empowering Industries with the Most Powerful Agentic Coding
Recently, Qiming Venture Partners portfolio company Zhipu AI officially released the GLM Coding Plan Enterprise Edition. Built on the industry-leading GLM-4.6 model, it provides global enterprises with comprehensive intelligent programming solutions in a safer, more efficient, and more cost-effective manner, accelerating enterprise digital transformation.
GLM-4.6, the strongest coding model domestically, has become the preferred choice for developers worldwide thanks to its outstanding performance and excellent reputation. It ranks first on the international API platform OpenRouter's trending chart and has been certified by multiple open-source AI coding tools as the "fastest-adopted model." The world-leading AI open-source coding assistant Kilo Code saw its token consumption grow from 168 million to 15.9 billion in just 12 days.
Building on this foundation, Zhipu AI has gone further by officially launching the GLM Coding Plan Enterprise Edition, integrating multimodal understanding (image/video), web-connected search (MCP), and intelligent orchestration capabilities to provide enterprise teams with a one-stop solution from code generation to full-chain development collaboration.
02/
Unisound Brings AGI to Smart Living
Launches "Smart Photo Learning Device" and Multiple "Smart Hardware + Large Model" Solutions
Recently, Qiming Venture Partners portfolio company Unisound (09678.HK) unveiled a series of new products and solution upgrades across its smart living product line, with large models fully integrated into its product portfolio — bringing AGI from a "technical concept" into practical, everyday smart living.
After an important meeting, staff can review a recording and within minutes locate key speaking details, extract important summaries, and generate meeting minutes or draft work reports based on the content. A child with a "Smart Photo Learning Device" can snap pictures of interesting animals, plants, text, or patterns and ask questions in real time, with the AI providing vivid, interactive explanations — these once "dreamlike scenarios" are now being made reality by Unisound's "smart hardware + large model" combination. Leveraging its full-stack AI technology and self-developed "Shanhai Large Model," Unisound has partnered with industry players to launch multiple smart hardware solutions, upgrading office, education, consumer electronics, and other living scenarios by transforming ordinary hardware into intelligent problem-solving assistants.
03/
Mech-Mind Unveils New Humanoid Robot Autonomous Shelf-Picking Solution
Recently, Qiming Venture Partners portfolio company Mech-Mind launched a new humanoid robot autonomous shelf-picking solution. The solution integrates multiple cutting-edge embodied artificial intelligence technologies and products including high-precision 3D cameras, AI software, five-finger dexterous hands, and full-size wheeled humanoid robots. Based on Mech-Mind's self-developed general-purpose robot "eyes, brain, and hands," the humanoid robot can generalize recognition and precisely manipulate real products of various forms, achieving fully autonomous "unmanned" operation across the entire workflow from order receipt to product retrieval and delivery.
With powerful generalization capabilities and environmental adaptability, the Mech-Mind humanoid robot autonomous shelf-picking solution can be flexibly deployed across supermarkets, retail, research, exhibitions, and other domains, providing diverse services including greeting, interaction, guided tours, and vending. The solution is highly integrated and standardized, requiring only one week for standard localized deployment, while also supporting feature customization and multi-language interaction to meet diverse scenario requirements.
Technology & R&D
01/
UBTECH Appears at IROS 2025
Showcasing Latest Technology and Applications Across Multiple Scenarios
Recently, the 2025 IEEE/RSJ International Conference on Intelligent Robots and Systems — a top global robotics event — was held in Hangzhou. As one of the most influential international conferences in robotics, IROS 2025 brought together over 6,000 leading experts, scholars, and industry representatives from around the world to discuss the deep integration of AI and robotics technology. A paper submitted by Qiming Venture Partners portfolio company UBTECH (09880.HK) Research Institute was selected for IROS 2025 and invited for presentation, revealing the latest advances in humanoid binocular vision. Additionally, UBTECH technical experts were invited to participate in technical seminars, introducing the model architecture, technical roadmap, and training methods of their self-developed multimodal large model Thinker.
At the exhibition, UBTECH, together with the Beijing Humanoid Robot Innovation Center, showcased flagship products including Embodied Tiangong, Huisi Kaiwu, and Tiangong Xingzhe, presenting a comprehensive display of full-size humanoid robot frontier technology, innovative achievements, and developer ecosystem.
02/
Jasmed Medical Exhibits at RCOST in Thailand
Promoting Orthopedic Innovation Through Chinese Smart Manufacturing
Recently, Qiming Venture Partners portfolio company Jasmed Medical exhibited at RCOST 2025 in Thailand. At the exhibition, Jasmed showcased key and innovative products from its six major product lines, demonstrating leading product capabilities through exceptional solutions and joining hands with global partners to shape the industry's future.
During the event, the Jasmed booth welcomed orthopedic professionals from around the world for in-depth discussions on cutting-edge topics such as knee-preserving technology and smart healthcare. Through high-quality dialogue, Jasmed shared its innovative design philosophy while drawing on valuable global orthopedic clinical experience, jointly mapping out a new blueprint for orthopedic technology development.
03/
VINNO at the 10th CCUSG Critical Care Ultrasound Academic Annual Conference
Recently, the 10th CCUSG Critical Care Ultrasound Academic Annual Conference opened in Chengdu under the theme "Evolution and Emergence," bringing together global experts to explore the clinical advancement of critical care ultrasound. Qiming Venture Partners portfolio company VINNO participated with the VINNO 10P portable ultrasound, designed specifically for clinical applications. Leveraging its technical advantages of "precision made accessible, intelligent monitoring," VINNO helped build a new paradigm for critical care ultrasound based on clinical reasoning chains, making advanced ultrasound technology — combining speed and efficiency — a "precision instrument" for safeguarding critically ill patients' lives.
VINNO also hosted concurrent training programs during the conference, including a critical care ultrasound fundamentals course, a critical care lung ultrasound workshop, and a critical care ultrasound and neonatology workshop. Using a "theory plus hands-on practice" teaching model, these programs helped young physicians rapidly master core critical care ultrasound skills, extending the ability to "precisely capture vital signs" to more clinical scenarios.
Company Honors
01/
WeRide and Cornerstone Robotics
Named to Wealth China's Best Design List 2025
Recently, the 2025 Wealth China Best Design List was officially unveiled. Wealth (China edition) has compiled this list for four consecutive years. This year's selected projects collectively present a profound dialogue between technology and humanity, highlighting the core value of human designers in the AI era — deep empathy and insight, defining complex problems, and endowing technology with warmth and meaning.
Qiming Venture Partners portfolio companies WeRide (NASDAQ: WRD), with its Robotaxi GXR, and Cornerstone Robotics, with its Siteng laparoscopic surgical robot, were named to the list.
Wealth (China edition) observed that AI is becoming designers' "super external brain," but the ability to generate massive numbers of solutions cannot replace human value judgment. Instead, it pushes designers toward an even more central role — their role is shifting from creators of form to anchors of value.
02/
Over 10 Qiming Venture Partners Portfolio Companies
Named to 2025 Beijing Top 100 Private Enterprises Series List
Recently, the 2025 Beijing Top 100 Private Enterprises series list was officially released. The series includes the Beijing Top 100 Private Enterprises, Top 100 in Technology Innovation, Top 100 in Cultural Industries, Top 100 Specialized and Innovative Enterprises, and Outstanding Social Responsibility Cases. It aims to showcase the development trends and industrial layout of Beijing's private economy, identify a group of high-quality private enterprises that align with the "high-precision" economic structure and have demonstrative and leading effects, and encourage and guide private enterprises to practice new development concepts and promote high-quality development.
Qiming Venture Partners portfolio companies Xiaomi (01810.HK), Meituan (03690.HK), Roborock (688169.SH), Yuanxin Technology, HyperStrong (688411.SH), Zhipu AI, SinoCellTech (688520.SH), Unisound (09678.HK), Sinotau Pharmaceutical, Gan & Lee Pharmaceuticals (603087.SH), QSG (NASDAQ: QSG), 52TOYS, Sino Biological (301047.SZ), and Yuanxin Huibao were named to the list.
03/
UBTECH's Walker S2 Wins Top MUSE Design Award
Recently, Qiming Venture Partners portfolio company UBTECH's (09880.HK) new-generation industrial humanoid robot Walker S2 claimed the top award at the global creative design competition — the MUSE Design Awards — becoming the only humanoid robot worldwide to receive this honor in 2025.
Winning the MUSE Design Platinum Award, Walker S2 has proven with its capabilities China's design innovation strength and industrial application potential in the humanoid robot field. From creative design to product realization, from a representative of Chinese smart manufacturing to a global application benchmark, cutting-edge technological achievements from China are reshaping the value of intelligent manufacturing. As an AI representative of China's new quality productive forces, UBTECH is not only leading the industry's development direction but also opening a new chapter for the upgrade of global intelligent manufacturing.
04/
StepFun's Multimodal Capabilities Power HONOR's New Flagship Magic8 Series,
Winning Best Collaboration Award
Recently, HONOR held its 2025 Global Developers Conference and AI Terminal Ecosystem Conference, showcasing its newly released flagship Magic8 series and the latest self-evolving AI agent operating system MagicOS 10. The intelligent agent YOYO serves as an all-around companion, enabling convenient automatic execution across 3,000+ scenarios covering "food, clothing, housing, transportation, and shopping." At HONOR's AI sub-forum, Qiming Venture Partners portfolio company StepFun received the "Best Collaboration Award."
As an ecosystem partner of HONOR, StepFun's multimodal large model provides technical support for the YOYO intelligent agent, enabling YOYO Memory to accurately recognize and understand fragmented information, build exclusive personal knowledge bases for each user, and help YOYO Assistant develop more intelligent multimodal Q&A capabilities.
Past Highlights
Qiming Weekly | Qiming Venture Partners Portfolio Company Funding and Updates Vol. 37, 2025
Qiming Venture Partners was founded in 2006. The firm currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, Qiming has focused on investing in exceptional early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises. Among these, more than 210 have gone public on exchanges including the NYSE, NASDAQ, Hong Kong Exchanges and Clearing Limited, the Shanghai Stock Exchange, and the Shenzhen Stock Exchange, or have exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many of Qiming's portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), SinoCellTech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, and Biren Technology.